Learn more about data supporting guidelines, recommendations and recent advances regarding therapeutic options for patients with solid tumors and malignant and nonmalignant hematologic disorders.

On completing the program, learners will gain a deeper understanding of the pathogenesis, diagnostic evaluation and therapeutic modalities available for a breadth of solid tumors and hematologic disorders, and the ability to integrate guideline-based treatments, new therapeutic modalities and diagnostic approaches into clinical practice.

This educational program is intended for physicians, advanced practice providers, nurses, pharmacists, residents and fellows interested in a comprehensive update on solid tumors and hematologic disorders, and will be of interest to those certifying or re-certifying for their boards.

Topics :